title: STAR*D: a summary and UK perspective.
authors.affiliation: Fulbourn Hospital, Cambridge, UK. juliabrynja@gmail.com
authors.forename: J
authors.initials: J
authors.lastname: Deakin
authors.forename: C
authors.initials: C
authors.lastname: O'Loughlin
mesh_terms: D000928:Antidepressive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D003866:Depressive Disorder / Q000188:drug therapy* / Q000628:therapy; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D004359:Drug Therapy, Combination; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D016896:Treatment Outcome; D006113:United Kingdom
chemical_list: D000928:Antidepressive Agents; D018687:Antidepressive Agents, Second-Generation; D008996:Monoamine Oxidase Inhibitors